Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7821–7840 of 17,529 recalls

December 31, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Valsartan Tablets USP 10 mg/160 mg

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 26, 2018· Sun Pharmaceutical Industries, Inc.

Recalled Item: LOPERAMIDE HCL TABLETS USP

The Issue: Labeling Not Elsewhere Classified: The front panel indicates

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
December 26, 2018· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Estradiol Vaginal Inserts

The Issue: Defective Delivery System: Customer complaints of malfunctioning plunger

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 21, 2018· LUPIN SOMERSET

Recalled Item: Nitrofurantoin Oral Suspension

The Issue: Subpotent Drug: Expansion of June 2018 recall of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: Presence of Particulate Matter: Product complaints received of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 20, 2018· Allergan, PLC.

Recalled Item: OZURDEX (dexamethasone intravitreal implant) 0.7 mg)

The Issue: GMP Deviations: A silicone particulate was noted in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
December 20, 2018· Akorn Inc

Recalled Item: COSOPT Ophthalmic Solution

The Issue: Failed Stability Specifications: out of specification results for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
December 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: Presence of Particulate Matter: Product complaints received of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: Presence of Particulate Matter: Product complaints received of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: Presence of Particulate Matter: Product complaints received of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 20, 2018· Amerigen Pharmaceuticals Inc.

Recalled Item: Temozolomide Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
December 20, 2018· Amerigen Pharmaceuticals Inc.

Recalled Item: Temozolomide Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
December 19, 2018· Roberts Home Medical LLC

Recalled Item: Oxygen

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 19, 2018· Teva Pharmaceuticals USA

Recalled Item: Olmesartan Medoxomil and Hydrochlorothiazide Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 18, 2018· LGM Pharma LLC

Recalled Item: CIDOFOVIR DIHYDRATE

The Issue: CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund